TJC to Buy Majority Interest in Healthcare Events Company HMP Global
TJC will acquire a majority interest in HMP Global, backed by new event, product and acquisition plans, while Susquehanna Growth Equity retains a minority stake, with closing targeted for Q4 2026.
By Nathan Brooks
4 min read

What's News
- Investment funds managed by TJC agreed to acquire a majority interest in HMP Global.
- Susquehanna Growth Equity has backed HMP Global since 2008 and will retain a minority position.
- Financial terms were not disclosed; closing is expected in the fourth quarter of 2026, subject to customary approvals.
- TJC's investment targets four areas: existing operations, new product offerings, event launches and acquisitions.
- Jeff Hennessy Sr. will remain chairman and CEO, with HMP Global headquartered in Malvern, Pennsylvania.
By Nathan Brooks
Investment funds managed by TJC have agreed to acquire a majority interest in HMP Global, according to TJC and HMP Global. The companies expect the transaction to close in the fourth quarter of 2026, subject to customary approvals. The announcement did not disclose financial terms.
Susquehanna Growth Equity, which has invested in HMP Global since 2008, will retain a minority position. Under the announced structure, TJC-managed funds will become the majority owner while Susquehanna Growth Equity stays invested.
What TJC is buying
HMP Global operates medical conferences, clinical education programs, publishing properties and year-round professional communities, the company said. Its brands include Psych Congress, NEI Congress, the Symposium on Advanced Wound Care, Advances in IBD and EMS World Expo.
That portfolio gives TJC exposure to medical events, clinical education, publishing and year-round communities. It also adds HMP Collective, which develops custom programs for healthcare businesses.
Through HMP Collective, HMP develops custom content, education and community-engagement programs connecting healthcare businesses with clinical audiences, the company said.
TJC said its investment will support existing operations, new product offerings, event launches and acquisitions. The announcement did not assign spending totals or deadlines to those four priorities.
Jeff Hennessy Sr. will remain chairman and CEO, and HMP Global will retain its headquarters in Malvern, Pennsylvania, the companies said.
Hennessy framed the transaction as a funded continuation:
We have built HMP Global through trusted brands, strong clinical relationships and a team committed to improving patient care. We thank Scott Feldman, Amir Goldman, Sam Major, and the SGE team for helping us build the business we have today.
TJC shares our ambition for what comes next. Our next chapter will include investment in our existing businesses, new offerings and acquisitions that expand our influence in healthcare education and communications.
Hennessy's statement puts growth at the center of the next phase, while his commitment to invest in existing businesses keeps the current portfolio in view. He did not identify any acquisition targets or give a timetable for new products and events.
Dan Williams, partner and head of healthcare at TJC, said:
Jeff and his team have grown HMP Global and integrated acquisitions while keeping the mission of advancing patient care at the center of their focus.
We are proud to partner with them to invest in new event launches, the continued growth of HMP Collective and acquisitions that extend HMP Global’s reach to more healthcare professionals and the patients they serve.
Williams tied the new capital to three routes for expansion: new events, continued HMP Collective growth and acquisitions. The announcement does not specify an event count, spending total or revenue target.
Scott Feldman, managing director at Susquehanna Growth Equity, said:
It has been a privilege to partner with Jeff and the HMP Global team as they have transformed the company into a leading healthcare events and education platform.
Their vision, commitment to the healthcare communities they serve, and ability to continually evolve the business have been central to that success. We believe there is tremendous opportunity ahead and look forward to continuing our partnership alongside TJC.
Feldman's commitment to continue the partnership preserves Susquehanna Growth Equity's role after TJC-managed funds take the majority interest. Its backing since 2008 gives the transaction continuity, even as ownership changes.
What does this change for healthcare marketers?
For healthcare businesses using HMP Global's channels, the first-order change is the identity of the majority owner. HMP Collective links healthcare businesses with clinical audiences through custom content, education and community-engagement programs, according to the company.
TJC's investment gives those services a stated growth mandate: new products, event launches and acquisitions sit alongside support for existing operations. In practice, clients should watch for new HMP offerings and event calendars rather than assume an immediate change in pricing or service scope.
Hennessy remaining chairman and CEO provides management continuity. Susquehanna Growth Equity's continued minority position also gives the incumbent investor a financial stake in HMP Global's expansion under TJC.
The next proof points are new product releases, event launches, HMP Collective growth and acquisition announcements. For healthcare marketers and sponsors, those signals will carry more information than the undisclosed financial terms until TJC specifies spending and timing.
Source: pulse2.com
More from Nathan Brooks
Show full bio
News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.
2,611 articles